Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis

Gut

Volumn 34, Issue 12, 1993, Pages 1677-1680

  Goggin, P M ^a   Collins, D A ^a   Jazrawi, R P ^a   Jackson, P A ^a   Corbishley, C M ^a   Bourke, B E ^a   Northfield, T C ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; FEMALE; GASTRITIS; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; DUODENUM; DYSPEPSIA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; MALE; MIDDLE AGE; PREVALENCE; STOMACH; SUPPORT, NON-U.S. GOV'T;

EID: 0027493607     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.34.12.1677     Document Type: Article

References (30)

1. Armstrong, C.P.; Blower, A.L. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration Gut 1987 10.1136/gut.28.5.527 28 527
2. Goodwin, C.S.; Marshall, B.J.; Blincow, E.D.; Wilson, D.H.; Blackbourn, S.; Phillips, M. Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies J Clin Pathol 1988 10.1136/jcp.41.2.207 41 207
3. Coghlan, J.G.; Gilligan, D.; Humphries, H.; McKenna, D.; Dooley, C.; Sweeney, E. Campylobacter pylori and recurrence of duodenal ulcers-a 12-month follow-up study Lancet 1987 ii: 1109
4. Rauws, E.A.J.; Tytgat, G.N.J. Cure of duodenal ulcer with eradication of Helicobacter pylori Lancet 1990 10.1016/0140-6736(90)91301-P ii: 1233
5. George, L.L.; Borody, T.J.; Andrews, P.; Devine, M.; Moore-Jones, D.; Walton, M. Cure of duodenal ulcer after eradication of Helicobacter pylori MedjAust 1990 153 145
6. Rauws, E.A.; Langenberg, W.; Houthoff, H.J.; Zanen, H.C.; Tytgat, G.N. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study ofits prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988; 94 33
7. Farah, D.; Sturrock, R.D.; Russell, R.I. Peptic ulcer in rheumatoid arthritis Ann Rheum Dis 1988 10.1136/ard.47.6.478 47 478
8. Lanza, F.L. A review of gastric ulcer and gastroduodenal injury in normal volunteers receiving aspirin and other nonsteroidal anti-inflammatory drugs Scand J Gastroenterol 1989 10.3109/00365528909091171 163 24
9. Lambet, JR, Dunn; K, Borromeo; M, Korman; MG, Hansky; J. Campylobacter pylori-a role in non-ulcer dyspepsia? Scand J Gastroenterol 1989 160 7
10. Upadhyay, R.; Howatson, A.; McKinlay, A.; Danesh, B.J.; Sturrock, R.D.; Russell, R.I. Campylobacter pylori associated gastritis in patients with rheumatoid arthritis taking nonsteroidal antiinflammatory drugs Brj Rheumatol 1988 10.1093/rheumatology/27.2.113 27 113
11. Doube, A.; Morris, A. Nonsteroidal anti-inflammatory druginduced dyspepsia-is Campylobacter pyloridis implicated? Brj Rheumatol 1988 10.1093/rheumatology/27.2.110 27 110
12. Graham, D.Y.; Lidsky, M.D.; Cox, A.M.; DJ, Jr, Evans; Evans, D.G.; Alpert, L. Long-term nonsteroidal antiinflamtory drug use and Helicobacter pylori infection Gastroenterology 1991 10.1016/0016-5085(91)90665-8 100 1653
13. Lanza, F.L.; Royer, G.J.; Nelson, R.S. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa NEnglj Med 1980 10.1056/NEJM198007173030305 303 136
14. Marshall, B.J.; Warren, JR, Francis; GJ, SR, Langton Rapid urease test in the management of Campylobacter pyloridis associated gastritis Amj Gastroenterol 1987 82 200
15. Morris, A.; All, M.R.; Brown, P.; Lane, M.; Patton, K. Campylobacter pylori infection in biopsy specimens of gastric antrum: laboratory diagnosis and estimation of sampling error J Clin Pathol 1989 10.1136/jcp.42.7.727 42 727
16. Szeto, M.L.; Pounder, R.E.; Hamilton, D.S.; Dhillon, A.P. Rapid urease test provides specific identification of Campylobacter pylori in antral mucosal biopsies Postgrad Med J 1988 10.1136/pgmj.64.758.935 64 935
17. Whitehead, R.; Truelove, S.C.; Gear, M.W.L. The histological diagnosis of chronic gastritis in fibreoptic gastric biopsy specimens J Clin Pathol 1972 10.1136/jcp.25.1.1 25 1
18. Wyatt, J.I.; Rathbone, B.J. The role of serology in the diagnosis of Campylobacter pylori infection ScandJ Gastroenterol 1989 10.3109/00365528909091732 24 27 160
19. Iglehart, I.W.; Edlow, D.W.; Mills, L.J.; Morrison, S.A.; Hochberg, M.C. The presence of Campylobacter pylori in nonsteroidal antuinflammatory drug associated gastritis J Rheumatol 1989 16 599
20. Caselli, M.; Pazzi, P.; LaCorte, R.; Aleotti, A.; Trevisani, L.; Stabellini, G. Campylobacter-like organisms nonsteroidal anti-inflammatory drugs and gastric lesions in patients with rheumatoid arthritis Digestion 1989 10.1159/000199898 44 101
21. Jones, S.T.; Clague, R.B.; Eldridge, J.; Jones, D.M. Serological evidence of infection with Helicobacter pylori may predict gastrointestinal intolerance to non-steroidal anti-inflammatory drug (NSAID) treatment in rheumatoid arthritis BrJRheumatol 1991 30 16
22. Glupczynski, Y.; Delmee, M.; Bruck, C.; Labbe, M.; Avesani, V.; Burette, A. Susceptibility of clinical isolates of Campylobacter pylori to 24 antimicrobial and anti-ulcer agents EurJ Epidemiol 1988 10.1007/BF00144743 4 154
23. Lanza, F.L.; Evans, D.G.; Graham, D.Y. Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers AmJ Gastroenterol 1991 86 735
24. Heresbach, D.; Raoul, J.L.; Bretagne, J.F.; Minet, J.; Donnio, P.Y.; Ramee, M.P. Helicobacter pylori: a risk and severity factor of non-steroidal anti-inflammatory drug induced gastropathy Gut 1992 10.1136/gut.33.12.1608 33 1608
25. Graham, D.Y.; Smith, J.L.; Holmes, G.I.; Davies, R.O. Nonsteroidal anti-inflammatory effect of sulindac sulfoxide and sulfide on gastric mucosa Clin Pharmacol Ther 1985 10.1038/clpt.1985.136 38 65
26. Carson, J.L.; Strom, B.L.; Morse, M.L.; West, S.L.; Soper, K.A.; Stolley, P.D. The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs Arch Intern Med 1987 10.1001/archinte.1987.00370060050010 147 1054
27. Metzger, W.H.; McAdam, L.; Bluestone, R.; Guth, P.H. Acute gastric mucosal injury during continuous or interrupted aspirin ingestion in humans AmJDigDis 1976 21 963
28. Taha, A.S.; McLaughlin, S.; Holland, P.J.; Kelly, R.W.; Sturrock, R.D.; Russell, R.I. Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis Ann Rheun Dis 1990 10.1136/ard.49.6.354 49 354
29. Graham, D.Y.; Smith, J.L.; Dobbs, S.M. Gastric adaptation occurs with aspirin administration in man Dig Dis Sci 1983 10.1007/BF01393353 28 1
30. Graham, D.Y.; Smith, J.L.; Spiut, H.J.; Torres, E. Gastric adaptation. Studies in humans during continuous aspirin administration Gastroenterology 1988 95 327